半盐水在腹脂肪抽中的有效性
Kyungho Paik1, Nam Chul Kim2, Jeong Eun Kim2
1Department of Dermatology, Seoul National University Bundang Hospital, 82 Gumi-Ro 173 Beon-Gil, Seongnam, 13620, Gyeonggi, Korea.
Scientific reports
|December 22, 2025
概括
与正常盐水相比,使用半盐水的局部麻醉微创性脂肪抽 (LAMS) 在减少腰围和减肥方面表现出更高的有效性. 这种吸脂技术提供了改善的结果与半盐液瘤液.
科学领域:
- 整形外科 整形外科 整形外科
- 最少侵入性手术的方法
- 身体轮造型 身体轮造型
背景情况:
- 局部麻醉微创性抽脂 (LAMS) 是一种低压脂肪去除技术.
- 瘤流体的组成可能会影响LAMS的临床结果.
研究的目的:
- 为了比较使用半盐水与正常盐水化液的LAMS疗效和安全性.
- 为了评估发液类型对腹部脂肪减少结果的影响.
主要方法:
- 对147名接受LAMS治疗的患者进行了回顾性队列研究,以减少腹部脂肪.
- 患者被分为正常盐水 (n=46) 和半盐水 (n=101) 组.
- 临床结果,包括腰围变化,在同变量调整后进行了比较.
主要成果:
- 半盐水组与正常盐水组相比,腰围的减少在统计学上显著地更大.
- 在半盐溶液组中,观察到每提取脂肪体积的体重变化更大.
- 没有指定任何不良事件,但疗效偏好半盐水.
结论:
- 使用半盐水的腹液的LAMS在减小腰围方面似乎比正常盐水更有效.
- 半盐水可能会提高减肥效率,相对于LAMS过程中提取的脂肪量.
- 瘤流体组成是优化LAMS结果的关键因素.
相关概念视频
01:26Enhanced Elimination of Poison
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
01:23Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...